CoronaryAtlas logo
CoronaryAtlas
PC (20:3/20:4)
Pathway / Myocardial injury (shared endpoint)

PC (20:3/20:4)

lipid

Decreased PC (20:3/20:4) content post-MI reflects eicosanoid-precursor lipid depletion and myocardial dysfunction.

Pathway placement
Cascade stepMyocardial injury (shared endpoint)
Confidencemedium
RationaleDecreased arachidonic-acid-containing phosphatidylcholine predicts heart-failure after MI; injury and remodeling marker.
Also acts inSystemic / off-pathway
Druggability
Not assessed (no mapped human gene target).

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma (EDTA to limit oxidation)
Collection tube
K2/K3-EDTA (lavender-top) · Serum separator (gold/red-top, SST)
Method / principle
LC-MS/MS lipidomics (targeted or shotgun)
Reagent / substrate
Deuterated lipid-class internal standards; MS/MS transitions
Platform
LC-MS/MS
Turnaround · availability
Research · Research-only

Literature evidence(1)